TY  - JOUR
AU  - Vega, A.
AU  - Jimenez-Rodriguez, T-W
AU  - Barranco, R.
AU  - Bartra, J.
AU  - Dieguez, M. C.
AU  - Dona, I
AU  - Fernandez-Rivas, M.
AU  - Gandolfo-Cano, M.
AU  - Gastaminza-Lasarte, G.
AU  - Gonzalez-Mancebo, E.
AU  - Caballer, B. de la Hoz
AU  - Sanchez-Morillas, L.
AU  - Torres, M. J.
AU  - Berges-Gimeno, M. P.
AU  - Munoz-Cano, R.
PY  - 2021
DO  - 10.18176/jiaci.0712
SN  - 1018-9068
UR  - https://hdl.handle.net/10668/24474
T2  - Journal of investigational allergology and clinical immunology
AB  - Rapid drug desensitization has enabled first-line therapies in patients with drug hypersensitivity reactions to chemotherapeutic drugs including monoclonal antibodies. Desensitization is a safe and highly effective procedure, not only for IgE-mediated...
LA  - en
PB  - Esmon publicidad s a, dept allergy & clin immunol, clin univ navarra
KW  - Drug allergy
KW  - Drug hypersensitivity
KW  - Desensitization
KW  - Chemotherapy
KW  - Drug challenge
KW  - Monoclonal antibodies
KW  - Successful oral desensitization
KW  - Hereditary alpha-tryptasemia
KW  - Rapid drug desensitization
KW  - Basophil activation test
KW  - Stevens-johnson-syndrome
KW  - Monoclonal-antibodies
KW  - Ige desensitization
KW  - Skin-test
KW  - Carboplatin hypersensitivity
KW  - General-considerations
TI  - Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization
TY  - research article
VL  - 31
ER  -